Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ALLISON LAUREN GLASER

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1063758829
CMS profile
10584513
Location
NEW YORK, NY

General Payments · PY2021–2022

$446.91

  • Reported across 19 records
  • CMS publication 2026-01-23

Latest program year · PY2022

$409.13

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2022 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $409.13 17

By paying entity

PY2022 · sorted by reported total

Paying entityAmountRecords
OptiNose US, Inc. $180.35 7
AIMMUNE THERAPEUTICS, INC. $47.78 2
Incyte Corporation $44.32 2
GENZYME CORPORATION $30.82 1
Teva Pharmaceuticals USA, Inc. $28.68 1
GlaxoSmithKline, LLC. $27.44 1
Phadia US Inc. $22.05 1
Amgen Inc. $14.38 1
Acerta Pharma LLC $13.31 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $37.78 2
PY2022 $409.13 17

Payment records · PY2022 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2022 2021 Record-level detail is published for PY2022; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Aimmune Therapeutics, Inc. $21.95 02/15/2022 Food and Beverage Undisputed 01/23/2026 954228151 CMS
Aimmune Therapeutics, Inc. $25.83 03/22/2022 Food and Beverage Undisputed 01/23/2026 954231125 CMS
Amgen Inc. $14.38 02/15/2022 Food and Beverage Undisputed 01/23/2026 939572987 CMS
AstraZeneca Pharmaceuticals LP $13.31 05/10/2022 Food and Beverage Undisputed 01/23/2026 914807523 CMS
GENZYME CORPORATION $30.82 10/25/2022 Food and Beverage Undisputed 01/23/2026 939089247 CMS
GlaxoSmithKline, LLC. $27.44 11/08/2022 Food and Beverage Undisputed 01/23/2026 944475553 CMS
Incyte Corporation $22.81 03/09/2022 Food and Beverage Undisputed 01/23/2026 943071469 CMS
Incyte Corporation $21.51 06/14/2022 Food and Beverage Undisputed 01/23/2026 943071487 CMS
OptiNose US, Inc. $0.72 04/05/2022 Food and Beverage Undisputed 01/23/2026 928130413 CMS
OptiNose US, Inc. $11.56 04/05/2022 Food and Beverage Undisputed 01/23/2026 928130417 CMS
OptiNose US, Inc. $19.64 05/17/2022 Food and Beverage Undisputed 01/23/2026 928130493 CMS
OptiNose US, Inc. $3.10 07/12/2022 Food and Beverage Undisputed 01/23/2026 928130523 CMS
OptiNose US, Inc. $20.35 07/12/2022 Food and Beverage Undisputed 01/23/2026 928130527 CMS
OptiNose US, Inc. $114.56 09/12/2022 Food and Beverage Undisputed 01/23/2026 928130585 CMS
OptiNose US, Inc. $10.42 09/12/2022 Food and Beverage Undisputed 01/23/2026 928130613 CMS
Phadia US Inc. $22.05 02/22/2022 Food and Beverage Undisputed 01/23/2026 869296193 CMS
Teva Pharmaceuticals USA, Inc. $28.68 05/02/2022 Food and Beverage Undisputed 01/23/2026 954876857 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022
Source files
Dataset page · Bulk file · PY2021 , PY2022
Generated from
OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.